Akums Drugs & Pharmaceuticals Ltd share price logo

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

BSE: 544222

Small Cap

Pharma Sector

516.95

-10.95

(-2.07%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Akums Drugs Stock Performance

as on May 15, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹500.05
    ₹532.30
    downward going graph

    3.27%

    Downside

    2.97%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹409.30
    ₹622.95
    downward going graph

    20.82%

    Downside

    20.50%

    Upside

    downward going graph

Akums Drugs share price movements today

Previous Close
₹527.90
Open
₹531.70
Volume
3.88L
Upper Circuit
₹580.65
Lower Circuit
₹475.15
Day's Low - High
₹500.05 - ₹532.30
52 Week Low - High
₹409.30 - ₹622.95

Akums Drugs Historical Returns

1 Month Return
-3.19 %
3 Month Return
+ 10.62 %
1 Year Return
-5.39 %
3 Year Return
-33.7 %
5 Year Return
-33.7 %

Akums Drugs Fundamentals

as on May 15, 2026 at 4:01 pm IST

Market Cap

₹121.95 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Industry PE ratio

44.62

Beta (LTM)

1.31

P/B Ratio

-0.98

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-45.63

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

199.01

Akums Drugs Stock Valuation

as on May 15, 2026 at 4:01 pm IST

Akums Drugs in the last 5 years

  • Overview

  • Trends

Lowest (18.75x)

April 7, 2025

Today (31.67x)

May 14, 2026

Industry (44.62x)

May 14, 2026

Highest (66.86x)

August 19, 2024

LowHigh

Today’s Price to Earnings Ratio: 31.67x

Akums Drugs Technical Analysis

Track how Akums Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish9
Bullish3
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.59
Bullish
CCI (20)
-80.42
Neutral
RSI (14)
42.98
Neutral
Momentum (10)
0.3
Bullish
ADI (14)
33.48
Bullish
Ultimate Oscillator (7,14,28)
50.77
Neutral

Moving Averages

Name

Value

Action

SMA (20)
517.03
Bearish
EMA (20)
517.44
Bearish
VWMA (20)
517.06
Bearish
SMA (50)
519.27
Bearish
EMA (50)
518.87
Bearish
SMA (200)
521.79
Bearish
EMA (200)
521.18
Bearish
KAMA (200)
519.07
Bearish
DEMA (200)
519.52
Bearish

Akums Drugs & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Akums Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA121.95-10.57%0.00-2743
BUY7,462.18-11.6%0.004132,013
NA39.83-17.91%0.00-15142
NA132.89-10.46%0.003126
NA11.97-8.41%0.00-328

Market expectation of Akums Drugs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Akums Drugs Stock’s Investor Sentiment and Interest

Search interest for Akums Drugs & Pharmaceuticals Ltd Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Akums Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
969.89
1,181.25
1,082.84
944.21
1,019.11
1,033.09
1,010.41
1,055.55
1,024.03
1,017.53
1,159.59
1,157.87
Other Income
8.34
6.77
9.83
10.46
6.55
17.17
19.34
25.76
26.73
32.37
34.33
35.3
Total Income
978.23
1,188.03
1,092.67
954.67
1,025.66
1,050.26
1,029.75
1,081.31
1,050.76
1,049.9
1,193.92
1,193.17
Expenses
1,095.16
1,056.83
989.4
941.22
891.1
911.9
889.05
961.63
895.06
923.05
1,030.96
1,007.94
Operating Profit
-125.27
124.42
93.44
2.99
128.01
121.19
121.36
93.92
128.97
94.48
128.63
149.93
Operating Profit Margin %
-12.92%
10.53%
8.63%
0.32%
12.56%
11.73%
12.01%
8.9%
12.59%
9.29%
11.09%
12.95%
Profit Before Interest, Tax and Depreciation
-116.93
131.19
103.26
13.45
134.56
138.35
140.71
119.68
155.7
126.84
162.96
185.23
Interest
12.15
13.65
12.44
12.38
13.02
11.9
5.13
4.54
23.14
23.3
23.74
23.89
Depreciation
29.72
30.42
31.55
33.95
34.06
34.87
44.52
40
36.92
37.86
39.65
40.12
Profit Before Tax
-158.8
87.12
59.27
-32.88
87.48
91.58
91.06
75.14
95.64
65.68
99.57
121.22
Tax Paid
28.64
54.43
-135.72
6.59
26.28
24.94
24.75
-74.47
30.96
22.98
31.89
39.87
Profit After Tax
-187.43
32.69
195
-39.47
61.21
66.65
66.31
149.61
64.69
42.7
67.67
81.34
Total Net profit including share of profit / Loss from associate company
-187.43
32.69
195
-39.47
61.21
66.65
66.31
149.61
64.69
42.7
67.67
81.34
EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66
4.33
5.53
Actual EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66
4.33
5.53
Adjusted EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66
4.33
5.53
Diluted EPS
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26
9.64
4.15
2.66
4.33
5.53

Akums Drugs & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
3,671.89
3,654.82
4,178.18
4,118.16
4,359.02
Other Income
22.83
46.11
34.03
68.82
128.73
Total Income
3,694.73
3,700.93
4,212.21
4,186.98
4,487.74
Expenses
3,776.59
3,391.57
4,081.23
3,653.68
3,857.02
Operating Profit
-104.7
263.25
96.95
464.48
502
Operating Profit Margin %
-2.85%
7.2%
2.32%
11.28%
11.52%
Profit Before Interest, Tax and Depreciation
-81.86
309.35
130.98
533.3
630.73
Interest
16.66
46.25
50.61
34.6
94.07
Depreciation
94.68
112.81
125.64
153.45
154.55
Profit Before Tax
-193.2
150.29
-45.27
345.25
382.11
Tax Paid
57.68
52.48
-46.07
1.48
125.71
Profit After Tax
-250.87
97.82
0.79
343.78
256.4
Total Net profit including share of profit / Loss from associate company
-250.87
97.82
0.79
343.78
256.4
EPS
-17.65
6.63
-0.28
22.6
16.67
Actual EPS
-17.65
6.63
-0.28
22.6
16.67
Adjusted EPS
-8.82
6.63
-0.28
22.6
16.67
Diluted EPS
-17.65
6.63
-0.28
22.6
16.67

Akums Drugs & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
89.14
28.13
130.61
31.85
176.63
498.26
465.2
Cash Flow from Investing Activities
-122.95
-189.86
-108.87
-234.82
-304.7
-330.8
-547.83
Cash Flow from Financing Activities
37.39
233.02
-91.47
236.04
124.54
-108.03
72.79
Net Cash Flow
3.57
71.28
-69.72
33.07
-3.53
59.44
-9.86

Akums Drugs Stock Shareholding Pattern

Numbers in percentages

Feb 2024
Aug 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
84.91%
75.26%
75.26%
75.26%
75.26%
75.26%
75.26%
75.26%
75.26%
DII
0%
6.43%
7.52%
7%
7.4%
8.85%
9.28%
14.4%
14.35%
FII
0%
0%
7.34%
6.36%
5.77%
4.24%
2.28%
1.15%
1.37%
Public
0%
9.09%
7.15%
8.65%
8.85%
8.93%
10.46%
6.46%
6.29%
Total Outstanding Shares
14,30,64,350
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
15,73,93,988
Total Shareholders
8
1,38,205
57,531
68,410
69,366
69,424
75,365
76,869
72,589

Mutual Funds that own Akums Drugs Stock

Check out the Mutual Funds with significant holdings in Akums Drugs.

Akums Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Akums Drugs.

  • Akums Drugs & Pharmaceuticals Ltd Earnings Results

    Akums Drugs & Pharmaceuticals Ltd’s net profit fell -42.68% since last year same period to ₹84.61Cr in the Q4 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 27.58% jump in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Akums Drugs Stock

Check stock indices that include Akums Drugs.

BSE Healthcare

₹47,193.13

0.18 (84.87%)

Insights on Akums Drugs & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.15% to 1.37% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, AKUMS stock has moved up by 19.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 75.26% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 11.23% to 10.95% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.46% to 6.29% in Mar 2026 quarter

About Akums Drugs & Pharmaceuticals Ltd



Revenue: ₹1,157.87Cr as on March 2026 (Q4 FY26)
Net Profit: ₹81.34Cr as on March 2026 (Q4 FY26)
Listing date: 06 Aug, 2024
OrganisationAkums Drugs & Pharmaceuticals Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Akums Drugs share price today?

Akums Drugs share price today stands at ₹516.95 as on at the close of the market. Akums Drugs share today touched a day high of ₹532.3 and a low of ₹500.05.

What is the 52 week high and 52 week low range for Akums Drugs share?

Akums Drugs touched a 52 week high of ₹622.95 and a 52 week low of ₹409.3. Akums Drugs share price today i.e. is closed at ₹516.95, which is -17.02% down from its 52 week high and 26.30% up from its 52 week low.

What is Akums Drugs's market capitalisation today?

Akums Drugs market capitalisation is ₹8,308.83 Cr as on .

How to buy Akums Drugs shares?

To buy Akums Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AKUMS or Akums Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Akums Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Akums Drugs trading volume today?

Akums Drugs trading volume is 3.88L as on . This means that 3.88L shares of Akums Drugs were bought and sold on the stock market during today's trading session.